Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort

BACKGROUND: Esophageal adenocarcinoma patients have limited treatment options. TGF-β can be upregulated in esophageal adenocarcinoma, and blocking this pathway may enhance clinical response to PD-(L)1 inhibitors. Bintrafusp alfa is a first-in-class bifunctional fusion protein composed of the extrace...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Benjamin, Khattak, Adnan, Felip, Enriqueta, Kelly, Karen, Rich, Patricia, Wang, Ding, Helwig, Christoph, Dussault, Isabelle, Ojalvo, Laureen S., Isambert, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266790/
https://www.ncbi.nlm.nih.gov/pubmed/34009501
http://dx.doi.org/10.1007/s11523-021-00809-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266790/
https://www.ncbi.nlm.nih.gov/pubmed/34009501
http://dx.doi.org/10.1007/s11523-021-00809-2

Ejemplares similares